Prozac, a common medication used to combat depression, has been found to be less effective on patients with a specific gene set. People who have taken Prozac for two months but have shown no sign of improvement should opt for another treatment, says a medical report released by the Taipei Veterans General Hospital (TVGH). Tsai Shih-jen (蔡世仁), section chief of General Psychiatry at TVGH, said those with major depression carry genes that mitigate serotonin reuptake transporters, enhance monoamine oxidase, disrupt brain-derived neurotrophic factors, or generate serotonin 1A receptors that are more likely to be "Prozac-resistant."
Fri, Nov 17, 2006 - Page 3 News List
Taiwan Quick Take: Limitations found for Prozac
STAFF WRITER WITH AGENCIES
This story has been viewed 2024 times.
Listing from 2015-06-30 to 2015-07-07
- Most read
- Most e-mailed
1A-Rod gets milestone ball, settles dispute with club
2Nearly 1,000 rally against Kaohsiung industrial waste plan
3Water Park Inferno: Color Play Asia fire claims first fatality
4Oil, gold prices retreat on Greek crisis, Iranian oil
5Teachers urged not to use new books